Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells

Molecular and Cellular Biology

Volumn 24, Issue 16, 2004, Pages 7072-7081

  Gilbert, Stéphane ^a,b   Loranger, Anne ^b   Marceau, Normand ^a,b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Centre de Recherche HDQ   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FLICE INHIBITORY PROTEIN; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KERATIN 18; KERATIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; RAF PROTEIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CELL; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME REGULATION; EPITHELIUM CELL; IMMUNOCHEMISTRY; INTERMEDIATE FILAMENT; LIVER CELL; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HEPATOCYTES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINS; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; STATISTICS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 3543009577     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.16.7072-7081.2004     Document Type: Article

References (54)

1. Aoudjit, F., and K. Vuori. 2001. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-Flip and implications for anoikis. J. Cell Biol. 152:633-643.
2. Ashkenazi, A., and V. M. Dixit. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:255-260.
3. Baribault, H., J. Penner, R. V. Iozzo, and M. Wilson-Heiner. 1994. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:2964-2973.
4. Baribault, H., M. Wilson-Heiner, W. Muller, J. Penner, and N. Bakhiet. 1997. Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours. Transgenic Res. 6:359-367.
5. Bradley, J. R., and J. S. Pober. 2001. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20:6482-6491.
6. Brown, T. L., and P. H. Howe. 1998. MADD is highly homologous to a Rab3 guanine-nucleotide exchange protein (Rab3-GEP). Curr. Biol. 8:R191.
7. Bruder, J. T., G. Heidecker, and U. R. Rapp. 1992. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6:545-556.
8. Brulet, P., C. Babinet, R. Kemler, and F. Jacob. 1980. Monoclonal antibodies against trophectoderm-specific markers during mouse blastocyst formation. Proc. Natl. Acad. Sci. USA 77:4113-4117.
9. Caulin, C., C. F. Ware, T. M. Magin, and R. G. Oshima. 2000. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 149:17-22.
10. Coulombe, P. A., and M. B. Omary. 2002. "Hard" and "soft" principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14:110-122.
11. Deak, J. C., J. V. Cross, M. Lewis, Y. Qian, L. A. Parrott, C. W. Distelhorst, and D. J. Templeton. 1998. Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. Proc. Natl. Acad. Sci. USA 95:5595-5600.
12. Fukazawa, T., T. Fujiwara, F. Uno, F. Teraishi, Y. Kadowaki, T. Itoshima, Y. Takata, S. Kagawa, J. A. Roth, J. Tschopp, and N. Tanaka. 2001. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene 20:5225-5231.
13. Fulda, S., E. Meyer, and K. M. Debatin. 2000. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res. 60:3947-3956.
14. Galle, P. R., W. J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. H. Krammer, and L. Runkell. 1995. Involvement of the CD95 (APO-1/ fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
15. Gilbert, S., A. Loranger, N. Daigle, and N. Marceau. 2001. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J. Cell Biol. 154:763-773.
16. He, T., A. Stepulak, T. H. Holmstrom, M. B. Omary, and J. E. Eriksson. 2002. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J. Biol. Chem. 277:10767-10774.
17. Hingorani, S. R., and D. A. Tuveson. 2003. Ras redux: rethinking how and where Ras acts. Curr. Opin. Gen. Dev. 13:6-13.
18. Ho-Kim, M. A., A. Bédard, M. Vincent, and P. A. Rogers. 1991. Dystrophin: a sensitive and reliable immunochemical assay in tissue and cell culture homogenates. Biochem. Biophys. Res. Commun. 181:1164-1172.
19. Holmstrom, T. H., I. Schmitz, T. S. Soderstrom, M. Poukkula, V. L. Johnson, S. C. Chow, P. H. Krammer, and J. E. Eriksson. 2000. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19:5418-5428.
20. Inada, H., I. Izawa, M. Nishizawa, E. Fujita, T. Kiyono, T. Takahashi, T. Momoi, and M. Inagaki. 2001. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol. 155:415-426.
21. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L. E. French, and J. Tschopp. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
22. Jackson, B. W., C. Grund, E. Schmid, K. Burki, W. W. Franke, and K. Illmensee. 1980. Formation of cytoskeletal elements during mouse embryogenesis: intermediate filaments of the cytokeratin type and desmosomes in preimplantation embryos. Differentiation 17:161-179.
23. Jansen, R. P. 1999. RNA-cytoskeletal associations. FASEB J. 13:455-466.
24. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinen, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10:640-648.
25. Kaufmann, S. H., and M. O. Hengartner. 2001. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11:526-534.
26. Kim, Y., N. Suh, M. Sporn, and J. C. Reed. 2002. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 277:22320-22329.
27. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579-5588.
28. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3:409-413.
29. Kreuz, S., D. Siegmund, P. Scheurich, and H. Wajant. 2001. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21:3964-3973.
30. Ku, N. O., R. Gish, T. L. Wright, and M. B. Omary. 2001. Keratin 8 mutations in patients with cryptogenic liver disease. N. Engl. J. Med. 344:1580-1587.
31. Ku, N. O., T. L. Wright, N. A. Terrault, R. Gish, and M. B. Omary. 1997. Mutation of human keratin 18 in association with cryptogenic cirrhosis. J. Clin. Investig. 99:19-23.
32. Kwon, Y. H., A. Jovanovic, M. S. Serfas, H. Kiyokawa, and A. L. Tyner. 2002. P21 functions to maintain quiescence of p27-deficient hepatocytes. J. Biol. Chem. 277:41417-41422.
33. Lane, E. B., B. L. Hogan, M. Kurkinen, and J. I. Garrels. 1983. Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 303:701-704.
34. Liu, G., W. M. Grant, D. Persky, V. M. Latham, Jr., R. H. Singer, and J. Condeelis. 2002. Interactions of elongation factor 1alpha with F-actin and beta-actin mRNA: implications for anchoring mRNA in cell protrusions. Mol. Biol. Cell 13:579-592.
35. Loranger, A., S. Duclos, A. Grenier, J. Price, M. Wilson-Heiner, H. Baribault, and N. Marceau. 1997. Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am. J. Pathol. 151:1673-1683.
36. Mak, T. W., and W. C. Yeh. 2002. Signaling for survival and apoptosis in the immune system. Arthritis Res. 4:S243-S252.
37. Marceau, N. 1994. Epithelial cell lineages in developing, restoring, and transforming liver: evidence for the existence of a "differentiation window." Gut 35:294-296.
38. Marceau, N., A. Loranger, S. Gilbert, N. Daigle, and S. Champetier. 2001. Keratin-mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease. Biochem. Cell Biol. 79:543-555.
39. Micheau, O., and J. Tschopp. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190.
40. Moll, R., W. W. Franke, and D. L. Schiller. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
41. Nagata, S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33:29-55.
42. Natoli, G., A. Costanzo, A. Ianni, D. J. Templeton, J. R. Woodgett, C. Balsano, and M. Levrero. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275:200-203.
43. Oshima, R. G. 2002. Apoptosis and keratin intermediate filaments. Cell Death Differ. 9:486-492.
44. Park, S. J., Y. Y. Kim, J. W. Ju, B. G. Han, S. I. Park, and B. J. Park. 2001. Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem. Biophys. Res. Commun. 289:1205-1210.
45. Park, S. J., Y. Y. Kim, J. Y. Lim, G. J. Seo, J. Kim, S. I. Park, and B. J. Park. 2001. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase. Biochem. Biophys. Res. Commun. 287:1140-1147.
46. Roberts, R. A., N. H. James, and S. C. Cosulich. 2000. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis. Hepatology 31:420-427.
47. Royal, I., L. Raptis, B. J. Druker, and N. Marceau. 1996. Downregulation of cytokeratin 14 gene expression by the polyoma virus middle T antigen is dependent on c-Src association but independent of full transformation in rat liver nonparenchymal epithelial cells. Cell Growth Differ. 7:737-743.
48. Rudel, T., F. T. Zenke, T. H. Chuang, and G. M. Bokoch. 1998. p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J. Immunol. 160:7-11.
49. Rust, C., and G. J. Gores. 2000. Hepatocyte transplantation in acute liver failure: a new therapeutic option for the next millennium? Liver Transpl. 6:41-43.
50. Stumptner, C., M. B. Omary, P. Fickert, H. Denk, and K. Zatloukal. 2000. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model. Am. J. Pathol. 156:77-90.
51. Toyoshima, F., T. Moriguchi, and E. Nishida. 1997. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell Biol. 139:1005-1015.
52. Tran, S. E., T. H. Holmstrom, M. Ahonen, V. M. Kahari, and J. E. Eriksson. 2001. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276:16484-16490.
53. Tschopp, J., M. Irmler, and M. Thome. 1998. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:552-558.
54. Zatloukal, K., C. Stumptner, M. Lehner, H. Denk, H. Baribault, L. G. Eshkind. and W. W. Franke. 2000. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am. J. Pathol. 156:1263-1274.